NYSE:SQM Hits $42 as Lithium Market Wavers—Time to Buy the Dip or Wait?

NYSE:SQM Hits $42 as Lithium Market Wavers—Time to Buy the Dip or Wait?

SQM’s stock down 36% in three years despite booming EV growth forecasts—Is lithium's revival enough to justify investing at $42? | That's TradingNEWS

TradingNEWS Archive 3/10/2025 7:09:36 PM
Stocks SQM CVX XOM PBR

NYSE:SQM: A Deep-Dive into Lithium's Fallen Giant at $42.18

SQM’s Stock Crash Reflects More Panic Than Reality

Sociedad Química y Minera de Chile (NYSE:SQM) has been one of the most debated stocks in the commodities space recently, trading at $42.18—a significant drop of nearly 9.15% over the past twelve months. Investors who once admired SQM for its steady profits are now growing increasingly worried after the company's Q4 earnings showed signs of real struggle beneath the surface. Despite revenues in Q4 coming in above forecasts at $1.07 billion, beating market expectations by about 7%, earnings per share (EPS) drastically missed, landing at just $0.42, down from $0.74 one year ago—a troubling 40.9% decline. The net profit figures mirror this harsh reality, tumbling to $120.1 million, which represents a brutal fall from $205.9 million a year earlier—a staggering 40.9% decrease. This severe margin squeeze is traced back directly to lithium's price collapse, tumbling more than 80% from their 2022 peaks, pushing net margins to negative territory at -8.93%.

SQM’s Lithium Demand Prospects vs. Near-Term Margin Pain

When you think of SQM, lithium naturally dominates the narrative, accounting for roughly 43% of the firm’s profits. Investors in SQM have historically placed their bets based on lithium’s critical role in the electric vehicle (EV) revolution, and that bet still has legs. Data clearly supports robust lithium demand over the coming decade, especially as the global electric vehicle market is anticipated to explode from $317 billion in 2024 to an enormous $2.45 trillion by 2034—a 10-year compound annual growth rate (CAGR) of 22.69%. Given lithium's role in battery technology, it's clear SQM’s strategic positioning in this space remains critical. But with lithium prices hitting rock bottom, there's legitimate concern in the short term. Even so, sales volumes haven't slowed: quarterly lithium sales volumes grew steadily at a CAGR of roughly 16.4% over the past two years, and SQM anticipates a robust 17% growth in lithium sales volume in 2025 alone, matching expected global lithium market expansion. Recent quarterly lithium sales volumes have indeed risen steadily, hitting nearly 205,000 metric tons in 2024. At this trajectory, annual volumes could easily surpass 960,000 metric tons within the next decade. This solidifies the long-term case for sustained revenue recovery even amidst ongoing pricing volatility.

Valuation Realities: Is SQM at $42 Undervalued or a Value Trap?

With SQM trading at $42.18, valuation comes sharply into focus. Using the widely respected Graham's valuation model and assuming an optimistic EPS growth rate of 14.67%, SQM’s intrinsic value could potentially reach around $47, indicating roughly 11.4% upside from current market prices. The sharp 40.9% year-over-year EPS decline to $0.42 in the latest quarter has spooked investors, but projected sales growth driven by lithium's resurgence could restore investor confidence. From another angle, NYSE:SQM’s price-to-sales (P/S) ratio currently sits at a compressed level compared to its historical highs—another indication of possible undervaluation given a more bullish lithium demand outlook into 2025 and beyond. Even with current EPS weakness and diminished profitability, projected forward revenues could strongly support higher share prices, making the current $42.18 price level a potential entry opportunity.

Debt and Cash Flow Concerns Looming for SQM

However, not everything about SQM’s financial picture suggests easy sailing ahead. SQM’s balance sheet carries heavy baggage, with long-term liabilities standing at $3.73 billion—a significant load given the company's uneven free cash flow (FCF) generation. Over the past five years, average annual free cash flow hovered around $527.58 million, insufficient to comfortably cover its debt obligations while also maintaining generous dividends. Notably, in 2023 the company paid out roughly 70.49% of FCF in dividends, which, while attractive for investors seeking yield, may limit SQM’s financial flexibility. Given lithium's volatile pricing environment, such leverage and dividend payout pressures introduce real financial risks should lithium fail to recover substantially or should broader market downturns further compress margins.

Chilean Partnerships and Political Risks Ahead

Another critical element investors must understand is SQM’s partnership with Chile’s national copper giant, Codelco. Beginning in 2031, SQM will lose half of its revenue from the Salar de Atacama lithium site, a significant development since this facility represents roughly 40-50% of SQM’s lithium profits. Essentially, this translates to a potential 20-25% drop in overall lithium-generated revenues once the agreement takes effect. SQM will still manage operations, but oversight will be ceded to Codelco. To offset this, the company is aggressively expanding production capacity in Salar de Atacama, investing to ramp up production capacity from around 50,000-60,000 metric tons annually to 180,000 metric tons by 2028—a significant 200% increase from current production. Additional operations in Australia and China somewhat mitigate concentration risks in Chile, but investors must carefully evaluate the geopolitical and operational risks accompanying this shift.

Diversification Through Iodine Sales Provides Stability

SQM’s iodine segment, while less exciting, is the company’s quiet stabilizer, consistently accounting for 39% of gross profits. Quarterly iodine sales volumes have grown incrementally, adding just 0.1 thousand metric tons since 2022, with demand projected to rise only around 2% annually in 2025. Nevertheless, the steadiness of iodine markets provides critical diversification to insulate SQM against severe fluctuations in lithium prices. Stability in iodine revenues, which are primarily tied to healthcare applications like X-ray contrast media, offers investors an important buffer that mitigates some of the volatility associated with lithium.

Analysts Mixed, But Long-Term Upside Still Evident

The Street remains divided on SQM. Recently, Citi lowered their price target from $60 down to $54, citing continued pressure on margins and expenses. In contrast, others maintain more cautious views: Deutsche Bank trimmed its target slightly to $37 and maintained an "Underperform" rating, reflecting pessimism around lithium pricing and export challenges. Despite these cautious takes, bullish analysts continue to emphasize SQM's undeniable future growth from data-supported lithium demand acceleration and expansion plans. The projected lithium sales volume of 53,000 tons for Q4 2024 alone suggests robust business health, even if margins remain under temporary pressure. Consensus estimates reflect a solid 24% rebound in EBITDA expected in 2025, underscoring that the worst may indeed be behind SQM as lithium markets stabilize.

Technical Picture Mixed, Yet Opportunity May Be Here

Technically, SQM's stock currently trades at $42.18, significantly below key moving averages—the 50-day and 200-day moving averages sit at $39.01 and $38.88, respectively, suggesting bearish momentum but also indicating potential oversold conditions. Furthermore, the P/E ratio stands negative following the recent earnings slump. However, investors should note that the 50-day moving average has recently begun trending upwards, hinting at improving investor sentiment. SQM’s financial health ratios such as current ratio (2.94) and quick ratio (2.05) signal liquidity remains sufficient to manage short-term obligations, though its debt-to-equity ratio of 0.74 underscores ongoing leverage concerns. Short interest has moderated recently, decreasing roughly 17.6% YoY, perhaps signaling that bearish pressure could ease soon.

 

Buy, Sell, or Hold: Decisive Verdict at $42

At a market price of $42.18, NYSE:SQM appears undervalued based purely on long-term lithium demand forecasts and intrinsic value estimates. Yet, the challenges associated with its balance sheet, lithium price volatility, and upcoming revenue-sharing partnership with Codelco present considerable near-term hurdles. Despite these obstacles, SQM’s potential for significant long-term upside—aided by a projected EV-driven lithium boom—remains compelling enough for risk-tolerant investors. After weighing all these factors comprehensively, I rate NYSE:SQM a cautious, yet clear Buy at the current price of $42.18, with an expectation of meaningful price appreciation once near-term margin pressures abate and lithium demand fully recovers.

That's TradingNEWS